Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness.
Rachedi NS, Tang Y, Tai YY, Zhao J, Chauvet C, Grynblat J, Akoumia KKF, Estephan L, Torrino S, Sbai C, Ait-Mouffok A, Latoche JD, Al Aaraj Y, Brau F, Abélanet S, Clavel S, Zhang Y, Guillermier C, Kumar NVG, Tavakoli S, Mercier O, Risbano MG, Yao ZK, Yang G, Ouerfelli O, Lewis JS, Montani D, Humbert M, Steinhauser ML, Anderson CJ, Oldham WM, Perros F, Bertero T, Chan SY. Rachedi NS, et al. Among authors: grynblat j. Cell Metab. 2024 Apr 24:S1550-4131(24)00130-X. doi: 10.1016/j.cmet.2024.04.010. Online ahead of print. Cell Metab. 2024. PMID: 38701775
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors.
Grynblat J, Khouri C, Hlavaty A, Jais X, Savale L, Camille Chaumais M, Kularatne M, Jevnikar M, Boucly A, Antigny F, Perros F, Simonneau G, Sitbon O, Humbert M, Montani D; French PH Network PULMOTENSION investigators. Grynblat J, et al. Eur Respir J. 2024 May 2:2302158. doi: 10.1183/13993003.02158-2023. Online ahead of print. Eur Respir J. 2024. PMID: 38697649
Pulmonary vascular phenotype identified in patients with GDF2 (BMP9) or BMP10 variants: an international multicentre study.
Grynblat J, Bogaard HJ, Eyries M, Meyrignac O, Savale L, Jaïs X, Ghigna MR, Celant L, Meijboom L, Houweling AC, Levy M, Antigny F, Chaouat A, Cottin V, Guignabert C, Coulet F, Sitbon O, Bonnet D, Humbert M, Montani D; and the French PH Network PULMOTENSION Investigators. Grynblat J, et al. Eur Respir J. 2024 Apr 4;63(4):2301634. doi: 10.1183/13993003.01634-2023. Print 2024 Apr. Eur Respir J. 2024. PMID: 38514094 Review.
Pulmonary hypertension associated with diazoxide: the SUR1 paradox.
Montani D, Antigny F, Jutant EM, Chaumais MC, Le Ribeuz H, Grynblat J, Khouri C, Humbert M. Montani D, et al. Among authors: grynblat j. ERJ Open Res. 2023 Nov 13;9(6):00350-2023. doi: 10.1183/23120541.00350-2023. eCollection 2023 Nov. ERJ Open Res. 2023. PMID: 37965230 Free PMC article. Review.
Diagnosis and management of pulmonary veno-occlusive disease.
Solinas S, Boucly A, Beurnier A, Kularatne M, Grynblat J, Eyries M, Dorfmüller P, Sitbon O, Humbert M, Montani D. Solinas S, et al. Among authors: grynblat j. Expert Rev Respir Med. 2023 Jul-Dec;17(8):635-649. doi: 10.1080/17476348.2023.2247989. Epub 2023 Aug 21. Expert Rev Respir Med. 2023. PMID: 37578057 Review.
The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload.
Mulvaney EP, Renzo F, Adão R, Dupre E, Bialesova L, Salvatore V, Reid HM, Conceição G, Grynblat J, Llucià-Valldeperas A, Michel JB, Brás-Silva C, Laurent CE, Howard LS, Montani D, Humbert M, Vonk Noordegraaf A, Perros F, Mendes-Ferreira P, Kinsella BT. Mulvaney EP, et al. Among authors: grynblat j. Front Cardiovasc Med. 2022 Dec 14;9:1063967. doi: 10.3389/fcvm.2022.1063967. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36588576 Free PMC article.